Industry
Medical - Devices
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
March 13, 2024 | 10:15 am
Portfolio Pulse from Benzinga Insights
March 12, 2024 | 5:01 pm
Portfolio Pulse from Benzinga Newsdesk
February 06, 2024 | 1:11 pm
Portfolio Pulse from Benzinga Newsdesk
January 22, 2024 | 12:33 pm
Portfolio Pulse from Benzinga Newsdesk
January 09, 2024 | 1:10 pm
Portfolio Pulse from Happy Mohamed
December 26, 2023 | 1:04 pm
Portfolio Pulse from Benzinga Newsdesk
December 12, 2023 | 1:06 pm
Portfolio Pulse from Benzinga Newsdesk
November 09, 2023 | 12:24 pm
Portfolio Pulse from Benzinga Newsdesk
November 08, 2023 | 11:08 pm
Portfolio Pulse from totan@benzinga.com
November 08, 2023 | 9:45 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.